B cells and antibodies in CNS demyelinating disease

被引:180
作者
Cross, AH [1 ]
Trotter, JL [1 ]
Lyons, JA [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA
关键词
multiple sclerosis; experimental autoimmune encephalomyelitis; B cell; plasma cell; antibody;
D O I
10.1016/S0165-5728(00)00409-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is much evidence to implicate B cells, plasma cells, and their products in the pathogenesis of MS. Despite unequivocal evidence that the animal model for MS, EAE, is initiated by myelin-specific T cells, there is accumulating evidence of a role for B cells, plasma cells, and their products in EAE pathogenesis. The role(s) played by B cells, plasma cells, and antibodies in CNS inflammatory demyelinating diseases are likely to be multifactorial and complex, involving distinct and perhaps opposing roles for B cells versus antibody. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
[31]   Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease [J].
Weier, Katrin ;
Fonov, Vladimir ;
Aubert-Broche, Berengere ;
Arnold, Douglas L. ;
Banwell, Brenda ;
Collins, D. Louis .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (10) :1266-1278
[32]   Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease? [J].
Gernert, J. A. ;
Zimmermann, H. ;
Oswald, E. ;
Christmann, T. ;
Kuempfel, T. ;
Havla, J. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
[33]   CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease [J].
Rosenthal, Jacqueline F. ;
Hoffman, Benjamin M. ;
Tyor, William R. .
JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) :321-330
[35]   MRI signs of CNS demyelinating diseases [J].
Etemadifar, Masoud ;
Ashourizadeh, Helia ;
Nouri, Hosein ;
Kargaran, Parisa K. ;
Salari, Mehri ;
Rayani, Milad ;
Aghababaee, Ali ;
Abhari, Amir Parsa .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
[36]   The spectrum of post-vaccination inflammatory CNS demyelinating syndromes [J].
Karussis, Dimitrios ;
Petrou, Panayiota .
AUTOIMMUNITY REVIEWS, 2014, 13 (03) :215-224
[37]   New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases [J].
Di Pauli, Franziska ;
Reindl, Markus ;
Berger, Thomas .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 22 :35-37
[38]   Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease [J].
Haeusler, Darius ;
Haeusser-Kinzel, Silke ;
Feldmann, Linda ;
Torke, Sebastian ;
Lepennetier, Gildas ;
Bernard, Claude C. A. ;
Zamvil, Scott S. ;
Brueck, Wolfgang ;
Lehmann-Horn, Klaus ;
Weber, Martin S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (39) :9773-9778
[39]   AXL+SIGLEC6+dendritic cells in cerebrospinal fluid and brain tissues of patients with autoimmune inflammatory demyelinating disease of CNS [J].
Kang, Junho ;
Kim, Moonhang ;
Yoon, Da-Young ;
Kim, Woo-Seok ;
Choi, Seok-Jin ;
Kwon, Young-Nam ;
Kim, Won-Seok ;
Park, Sung-Hye ;
Sung, Jung-Joon ;
Park, Myungsun ;
Lee, Jung Seok ;
Park, Jong-Eun ;
Kim, Sung-Min .
CLINICAL IMMUNOLOGY, 2023, 253
[40]   A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease [J].
Ochoa-Reparaz, J. ;
Mielcarz, D. W. ;
Wang, Y. ;
Begum-Haque, S. ;
Dasgupta, S. ;
Kasper, D. L. ;
Kasper, L. H. .
MUCOSAL IMMUNOLOGY, 2010, 3 (05) :487-495